TITLE

Lamictal XR

PUB. DATE
December 2007
SOURCE
Pharmaceutical Representative;Dec2007, Vol. 37 Issue 12, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the results of a medical trial on GlaxoSmithKline tablets. The results, published in the "Neurology" journal, suggest that an investigational, once-daily formulation of the firm's Lamictal, Lamictal XR extended release tablets decreases the frequency of partial seizures in patients with epilepsy. The trial included 239 patients age 13 and older who receive lamotrigine or placebo in addition to their antiepileptic medications.
ACCESSION #
27795316

 

Related Articles

  • Lamotrigine as an Effective Treatment for Behavioral Disorders. Rita Moretti; Paola Torre; Cristina Vilotti; Rodolfo M. Antonello // Letters in Drug Design & Discovery;Aug2007, Vol. 4 Issue 6, p446 

    Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In...

  • Eslicarbazepine Acetate: A Well-Kept Secret? Ben-Menachem, Elinor // Epilepsy Currents;Jan/Feb2010, Vol. 10 Issue 1, p7 

    PURPOSE: To study the efficacy and safety of eslicarbazepine acetate (ESL) as adjunctive therapy for refractory partial seizures in adults with ≥4 partial-onset seizures (simple or complex, with or without secondary generalization) per 4 weeks despite treatment with 1–2...

  • Lamotrigine in the Epilepsy Therapy at the Sarajevo Neurology Clinic. Alajbegovic, Azra; Alajbegovic, Salem; Todorovic, Ljubica // Materia Socio Medica;2010, Vol. 22 Issue 2, p85 

    Introduction: New antiepileptic drugs have opened a new era of therapy in the epilepsy treatment. The aim of this paper is to establish a therapeutic effect of the new antiepileptic (AE) as a supplement therapy in the treatment of those types of epilepsy which proved to be resistant to...

  • Carbamazepine and Lamotrigine Plasma Concentrations in Epileptic Patients during Optimising Therapy. Krasniqi, Shaip; Neziri, Burim; Islami, Hilmi; Bauer, Steffen // Medicinski Arhiv;2010, Vol. 64 Issue 2, p80 

    Therapeutic monitoring of antiepileptic drugs is important in process of optimisation of therapy of epileptic patients. Carbamazepine (CBZ) and Lamotrigine [LMT) are important drugs in therapy of epileptic patients which requires the monitoring of concentration of these drugs in serum. Our study...

  • Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: Audit of outcome. Walker, M.C.; Li, L.M. // BMJ: British Medical Journal (International Edition);11/09/96, Vol. 313 Issue 7066, p1184 

    Reports on the follow up audit of patients recruited from 1987 to 1989 to determine the effect of antiepileptic drugs on long term prognosis of refractory epilepsy as measured by mortality and freedom from seizures. Study on the effectiveness of lamotrigine and vigabatrin.

  • Examining the Clinical Utility of Lacosamide. Chung, Steve; Ben-Menachem, Elinor; Sperling, Michael R.; Rosenfeld, William; Fountain, Nathan B.; Benbadis, Selim; Hebert, David; Isojärvi, Jouko; Doty, Pamela // CNS Drugs;2010, Vol. 24 Issue 12, p1041 

    Background: Lacosamide is an antiepileptic drug (AED) approved for the adjunctive treatment of partial-onset seizures in adults. Completed phase II/III clinical trials of lacosamide provide a valuable opportunity to evaluate clinically relevant aspects of the resulting large patient pool....

  • Effect of Melatonin on Seizure Frequency in Intractable Epilepsy: A Pilot Study. Goldberg-Stern, Hadassa; Oren, Heftsiba; Peled, Nir; Garty, Ben-Zion // Journal of Child Neurology;Dec2012, Vol. 27 Issue 12, p1524 

    Melatonin is effective for treating sleep–wake cycle disturbances and has been reported occasionally to decrease epileptic seizure frequency, with no long-term side effects. In this pilot study, the investigators examined the effect of melatonin on seizures, sleep quality, and behavior in...

  • Lacosamide: What Can Be Expected from the Next New Antiepileptic Drug? Abou-Khalil, Bassel W. // Epilepsy Currents;Sep/Oct2009, Vol. 9 Issue 5, p133 

    PURPOSE: To evaluate the efficacy and safety of lacosamide (200 and 400 mg/day) when added to one to three concomitant antiepileptic drugs (AEDs) in patients with uncontrolled partial-onset seizures. METHODS: This multicenter, double-blind, placebo-controlled trial randomized patients (age...

  • Pregabalin: The Next New Thing. Faught, Edward // Epilepsy Currents;Nov/Dec2005, Vol. 5 Issue 6, p217 

    Discusses a study that evaluated the efficacy, tolerability and safety of two pregabalin regimens administered as adjunctive therapy to that of placebo in patients with medically refractory partial epilepsy. Mechanism of action of pregabalin; Factors considered in assessing the efficacy of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics